The FDA recently extended the deadlines for #DSCSA compliance (for Manufacturers and Repackagers, Wholesale Distributors and Dispensers with 26 or more full-time employees). We commend this decision, acknowledging the progress made and the challenges faced. Cencora remains committed to ensuring seamless and safeguarding the authenticity and traceability of pharmaceutical products. Learn more: https://ow.ly/Kxbb50Ub6Ef
关于我们
Besse Medical, a part of Cencora (formerly AmerisourceBergen), is one of the nation's largest and most trusted distributors of pharmaceuticals, vaccines, biological and basic ancillary supplies that serve community specialty physicians nationwide through our uniquely integrated specialty distribution network. We guarantee the integrity of the origin of all pharmaceutical products we sell by offering best-in-class service and drug management. We accelerate access to the products, insights, technology and guidance practices need to maximize practice effectiveness and efficiency and ultimately help healthcare providers elevate the patient experience by providing access to life-saving therapies. On August 30, 2023, Besse Medical became a subsidiary of Cencora when AmerisourceBergen changed its name to Cencora. There are no operational changes at this time. While many parts of our company are still doing business under different names, our purpose is shared. We are united in our responsibility to create healthier futures.
- 网站
-
https://www.besse.com/
Besse Medical的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- West Chester,OH
- 类型
- 上市公司
地点
-
主要
9075 Centre Pointe Drive
STE 140
US,OH,West Chester,45069
Besse Medical员工
动态
-
In the #buy-and-bill model, physicians are responsible for the upfront costs of purchasing products for in-office administration. Practices then bill payers for both the products and their administration, which alleviates the burden on patients to manage their own therapies—but ensuring cost recovery remains a critical concern.
-
Cencora is committed to partners to meet #DSCSA requirements. While the FDA’s exemption allows additional time to establish necessary data connections, preventing delays in medication delivery, we encourage all partners to maintain momentum towards full compliance. For more information, visit: https://ow.ly/hlCh50Ub6Qb
-
Cencora is committed to partners to meet #DSCSA requirements. While the FDA’s exemption allows additional time to establish necessary data connections, preventing delays in medication delivery, we encourage all partners to maintain momentum towards full compliance. For more information, visit: https://ow.ly/hlCh50Ub6Qb
-
Next week, our distribution centers will be closed for the Thanksgiving holiday. Please review the schedule and place your orders early so you have the necessary treatments for your patients. https://ow.ly/fxAJ50Ub5SV
-
It's not too late to sign up for a webinar to learn how it can help you maximize your reimbursement and streamline your billing processes. Register for Thursday, November 21 at 1 pm ET: https://ow.ly/T9mr50UaxTZ
-
Our Consulting Team is prepared to talk about CMS' Final Rule for #MIPS in a webinar on Thursday, December 5 at 1 pm ET / 12 noon CT. The team will provide Category updates, discuss the new MVPs, including those for urology and ophthalmology and provide some education around the Health Information Exchange measure for the Promoting Interoperability category. Register at: https://ow.ly/KpoJ50U9zot
-
We gather panel feedback regularly on contracting strategies, educational materials and third-party relationships, to ensure that the services and solutions we offer will work for all our #GPO members.